PWM
IMNM icon

Palumbo Wealth Management’s Immunome IMNM Stock Holding History

Palumbo Wealth Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$701K Buy
32,051
+1,073
+3% +$23.9K 0.17% 92
2025
Q4 		$665K Buy
30,978
+9,134
+42% +$160K 0.16% 98
2025
Q3 		$256K Buy
+21,844
New +$217K 0.08% 153

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Palumbo Wealth Management's IMNM Position: Q1 2026 in Review

Palumbo Wealth Management increased its Immunome (IMNM) stake by 3.5% in Q1 2026, buying an estimated $23.9K and bringing the position to 32,051 shares worth $701K. The position accounts for 0.17% of the portfolio, ranked #92.

Palumbo Wealth Management first reported a position in IMNM in Q3 2025 and has held it in 3 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Palumbo Wealth Management held 32,051 shares of Immunome worth $701K as of Q1 2026.
  • Palumbo Wealth Management bought 1,073 Immunome shares in Q1 2026, an estimated $23.9K.
  • Immunome made up 0.17% of Palumbo Wealth Management's portfolio in Q1 2026, its #92 holding.
  • Palumbo Wealth Management first reported a position in Immunome in Q3 2025 and has held it in 3 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Palumbo Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.